A new study under consideration at BMC Microbiology and published on the Research Square* preprint server describes a potential relationship between antibody titers against the rubella virus and the ...
In Portugal, the recommended age for the second dose of MMR (MMR2) was changed from 10–13 years to 5–6 years for those born in 1994 and afterwards. This study aimed to assess if MMR schedule and time ...
People with lower levels of antibodies against mumps -- the second "M" in the MMR vaccine -- are likelier to have a severe case of COVID. Vaccines must be rigorously tested before they are deployed en ...
A single dose of measles and rubella (MR) vaccine delivered to adults by the Vaxxas high-density microarray patch (HD-MAP) provided antibody responses comparable to the same vaccine delivered by ...
When public health officials make policies about when and how vaccination programs are implemented, they must weigh the benefits and risks of how infectious diseases spread throughout the country.
Passive immunization is a method that helps prevent rubella in those who are exposed or susceptible to the disease. In this strategy, ready-made IgG antibodies against rubella are administered.
An international team developed a new model, based on a case study of Nigeria, that may help public health officials accelerate the introduction of rubella vaccination in countries that have yet to do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback